» Articles » PMID: 35195565

Relationship Between COVID-19 Lockdown and Epidemiology of Neonatal Sepsis

Overview
Specialty Pediatrics
Date 2022 Feb 23
PMID 35195565
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We compared the hospital-based epidemiology of neonatal sepsis after the coronavirus disease 2019 lockdown (LD) versus historical epochs and the LD period versus phases of unlocking.

Methods: This retrospective cohort study was conducted in a level 3 neonatal unit. We compared neonates born in three 24-week periods-Group LD: 22 March 2020 to 5 September 2020-the reference group, Group pre-LD: 29 September 2019 to 14 March 2020 and Group temporally corresponding to LD in 2019 (corres-LD): 24 March 2019 to 7 September 2019. We also studied linear trends from LD phase 1.0 until Unlock 4.0. The key outcome was culture-positive sepsis.

Results: There were 1622, 2744 and 2700 subjects in groups LD, pre-LD and corres-LD, respectively. The incidence of any culture-positive sepsis in pre-LD was higher than LD [odds ratio (95% CI) = 1.61 (1.02-2.56)]. This was mainly due to a statistically significant reduction in Acinetobacter baumannii sepsis, with incidence rate differences of pre-LD versus LD [0.67 (95% CI: 0.37-0.97), P = 0.0001] and corres-LD versus LD [0.40 (95% CI: 0.16-0.64), P = 0.0024]. Groups pre-LD and corres-LD had higher proportion of multi-drug resistant (MDR)/extreme drug resistance/pan drug resistance sepsis than LD [77%, 77% and 44%, respectively (P values of both groups vs. LD = 0.01)]. From LD 1.0 to unlock 4.0, there were fewer episodes of MDR sepsis (Plinear trends = 0.047). On multivariable analysis, group pre-LD (vs. reference group LD), male sex, birth weight and Apgar score independently predicted culture-positive sepsis.

Conclusions: LD favorably impacted the epidemiology of neonatal sepsis in a hospital setting, with less A. baumannii and MDR sepsis, which persisted during unlocking.

Citing Articles

Impacts of COVID-19 pandemic on culture-proven sepsis in neonates.

Yang X, Ren L, Gong M, Lu Y, Ding X Front Cell Infect Microbiol. 2024; 14:1391929.

PMID: 38903936 PMC: 11186981. DOI: 10.3389/fcimb.2024.1391929.


A scoping review of bacterial resistance among inpatients amidst the COVID-19 pandemic.

Reffat N, Schwei R, Griffin M, Pop-Vicas A, Schulz L, Pulia M J Glob Antimicrob Resist. 2024; 38:49-65.

PMID: 38789083 PMC: 11392638. DOI: 10.1016/j.jgar.2024.05.010.


Epidemiologic features of neonatal sepsis and its COVID-19 associated temporal patterns in Jimma Medical Center, Ethiopia: A Joinpoint regression analysis.

Geleta D, Abebe G, Workneh N, Beyene G PLoS One. 2023; 18(11):e0291610.

PMID: 37917743 PMC: 10621950. DOI: 10.1371/journal.pone.0291610.


Surveillance of Multidrug-Resistant Pathogens in Neonatal Intensive Care Units of Palermo, Italy, during SARS-CoV-2 Pandemic.

Graziano G, Notarbartolo V, Priano W, Maida C, Insinga V, Rinaudo G Antibiotics (Basel). 2023; 12(9).

PMID: 37760753 PMC: 10525448. DOI: 10.3390/antibiotics12091457.